Studies published in Nature Communications reveal new chemical compounds with the potential to confer important health benefits in the elderly
Researchers at AdventHealth are giving consumers potentially lifesaving information about their heart health with a first-of-its-kind DNA study in Florida
Researchers from across the country, including AdventHealth’s Translational Research Institute for Metabolism and Diabetes, today released the results from the first definitive, large-scale clinical...
Doctors at AdventHealth performed the first U.S. procedure in a pilot study that researchers hope will lead to a groundbreaking new treatment for patients with type 2 diabetes.
Known as MoTrPAC, the study will involve up to 2,000 participants taking part in a 12-week exercise program to learn why exercise is good for us on the molecular level.
AdventHealth Orlando has been recognized as the No. 1 hospital in Florida and the top in Orlando by U.S. News & World Report, which released its 2019-20 Best Hospitals ratings today.
The study, a first-of-its-kind in Central Florida, aims to determine if and how the performing arts can improve health and quality of life.
Muscle cells from AdventHealth’s Translational Research Institute will be used to develop treatments for age-related muscle loss.
The TransEnterix Senhance system offers innovative features that benefit both patients and surgeons.
AdventHealth has made the Hospitals & Health Networks list of Most Wired Hospitals and Health Systems.